Company / Total Assets
Biofrontera Inc. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$28.6M
FY2025
5-year range
$22.1M / $53.2M
FY2021-FY2025
Trend
+29.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $29M.
Based on SEC 10-K filings.
$29M in FY2025 with a 3-year CAGR of -18.7%.
Improved from $28M to $29M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -18.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -18.7%, indicating a declining trend.
- In FY2025, total assets increased 29.2% year-over-year.
- Peak total assets was recorded in FY2022.
- Lowest total assets in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.6M | +29.2% |
| FY2024 | $22.1M | -20.9% |
| FY2023 | $27.9M | -47.5% |
| FY2022 | $53.2M | +0.0% |
| FY2021 | $53.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026